Shortage Watch Free FDA drug-shortage watch

← all medications

Dobutamine Hydrochloride Injection

Brand names: Dobutamine, Dobutamine Hydrochloride In Dextrose, Dobutamine In Dextrose

Category: Cardiovascular, Pediatric, Renal

Unavailable 1Available 9

FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Nov 6, 2017 (in shortage 8 years 10 months) · 3 manufacturers, 10 listed presentations

As of Sep 22, 2026, the FDA lists Dobutamine Hydrochloride Injection as currently in shortage. Of 10 manufacturer presentations, 1 Unavailable, 9 Available.

Ask your pharmacist: which of the 3 manufacturers below can they order right now, and whether a different strength or form of Dobutamine Hydrochloride Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)
NDC 0338-1073-02		 Baxter Healthcare Available -
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)
NDC 0338-1075-02		 Baxter Healthcare Available -
Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)
NDC 70436-203-80		 Hainan Poly Pharm. Co., Ltd. Available Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)
NDC 0338-1077-02		 Baxter Healthcare Available -
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10)
NDC 0409-1100-10		 Hospira, Inc., a Pfizer Company Available -
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10)
NDC 0409-0025-10		 Hospira, Inc., a Pfizer Company Available -
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10)
NDC 0409-0151-10		 Hospira, Inc., a Pfizer Company Available -
Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)
NDC 0409-2344-01		 Hospira, Inc., a Pfizer Company Available -
Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)
NDC 0409-2344-02		 Hospira, Inc., a Pfizer Company Available -
Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)
NDC 0409-2344-88		 Hospira, Inc., a Pfizer Company Unavailable Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

Related medications in shortage

Other Cardiovascular, Pediatric, Renal medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Dobutamine Hydrochloride Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Dobutamine Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Dobutamine Hydrochloride Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/dobutamine-hydrochloride-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).